Ibm Retirement Fund Regeneron Pharmaceuticals, Inc. Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$548.35 - $738.84 $893,810 - $1.2 Million	-1,630 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $23,209 - $27,238	-39 Reduced 2.34%	1,630 $1.14 Million
Q4 2021 Jan 19, 2022	SELL	$543.48 - $670.97 $630,980 - $778,996	-1,161 Reduced 41.02%	1,669 $1.05 Million
Q3 2021 Oct 05, 2021	BUY	$574.03 - $680.96 $4,592 - $5,447	8 Added 0.28%	2,830 $1.71 Million
Q2 2021 Jul 12, 2021	SELL	$472.8 - $558.54 $222,688 - $263,072	-471 Reduced 14.3%	2,822 $1.58 Million
Q1 2021 Apr 22, 2021	SELL	$446.73 - $548.2 $133,125 - $163,363	-298 Reduced 8.3%	3,293 $1.56 Million
Q4 2020 Jan 25, 2021	BUY	$478.3 - $607.98 $106,182 - $134,971	222 Added 6.59%	3,591 $1.74 Million
Q3 2020 Oct 16, 2020	BUY	$544.75 - $658.21 $481,014 - $581,199	883 Added 35.52%	3,369 $1.89 Million
Q2 2020 Jul 08, 2020	BUY	$493.32 - $643.92 $162,302 - $211,849	329 Added 15.25%	2,486 $1.55 Million
Q1 2020 Apr 07, 2020	BUY	$336.18 - $494.43 $244,402 - $359,450	727 Added 50.84%	2,157 $1.05 Million
Q4 2019 Jan 07, 2020	SELL	$274.13 - $376.51 $12,884 - $17,695	-47 Reduced 3.18%	1,430 $537,000
Q3 2019 Nov 06, 2019	SELL	$273.46 - $318.39 $4,101 - $4,775	-15 Reduced 1.01%	1,477 $410,000
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $9,287 - $12,859	31 Added 2.12%	1,492 $467,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $15,627 - $18,461	42 Added 2.96%	1,461 $600,000
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $36,268 - $43,528	-108 Reduced 7.07%	1,419 $530,000
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $78,655 - $91,506	-224 Reduced 12.79%	1,527 $617,000
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $61,473 - $74,517	-216 Reduced 10.98%	1,751 $604,000
Q1 2018 May 10, 2018	SELL	$315.82 - $393.78 $7,895 - $9,844	-25 Reduced 1.26%	1,967 $677,000
Q4 2017 Feb 07, 2018	BUY	$358.63 - $469.95 $8,607 - $11,278	24 Added 1.22%	1,992 $822,000
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $848,955 - $991,872	1,968	1,968 $969,000

Others Institutions Holding REGN

# of Institutions

1,480

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$7.59 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$7.13 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$6.98 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$4.08 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$3.91 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account